Source: Business Wire

Press Release: NantHealth : NantKwest Expands NANT Cancer Vaccine Program With Additional Clinical Trials Announced Addressing Multiple Cancer Types Across All Stages of Disease

CULVER CITY, Calif.--(BUSINESS WIRE)--NantKwest and Nantworks today announced at the 2017 Annual American Society for Clinical Oncology meeting (ASCO) in Chicago, IL the expansion of the company's existing NANT Cancer Vaccine program in pancreatic cancer (ClinicalTrials.gov NCT03136406) to target a number of additional tumor types. The NANT Cancer Vaccine program is a personalized, molecularly-informed therapy guided by NantHealth's GPS Cancer test that includes the simultaneous combination of

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Patrick Soon-Shiong's photo - Chairman & CEO of NantHealth

Chairman & CEO

Patrick Soon-Shiong

CEO Approval Rating

89/100

NantHealth is a cloud-based medical Information Technology platform that enables medical professionals to share and deliver healthcare information. Read more